Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 CAD | -9.09% | -1.96% | -22.48% |
Apr. 23 | MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 22 | MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index | CI |
Sales 2024 * | 280K 205K | Sales 2025 * | - | Capitalization | 51.64M 37.75M |
---|---|---|---|---|---|
Net income 2024 * | -5M -3.66M | Net income 2025 * | - | EV / Sales 2024 * | 184 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
10
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.21% |
1 day | -9.09% | ||
1 week | -1.96% | ||
Current month | -20.00% | ||
1 month | -17.36% | ||
3 months | -29.58% | ||
6 months | +7.53% | ||
Current year | -22.48% |
Managers | Title | Age | Since |
---|---|---|---|
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Todd Lahti
DFI | Director of Finance/CFO | 58 | 18-12-16 |
Colin Bletsky
COO | Chief Operating Officer | 49 | 18-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Quigley
BRD | Director/Board Member | 50 | 19-07-16 |
Brad Munro
CHM | Chairman | 64 | 18-03-14 |
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1 | -9.09% | 126,703 |
24-04-25 | 1.1 | 0.00% | 400 |
24-04-24 | 1.1 | +4.76% | 49,400 |
24-04-23 | 1.05 | 0.00% | 14,100 |
24-04-22 | 1.05 | +2.94% | 29,170 |
Delayed Quote Toronto S.E., April 26, 2024 at 03:52 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-22.48% | 37.72M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MGRO Stock